• Call +1.858.633.0165 or Fax +1.858.633.0166 or Contact Us

Solanezumab Antibody – Human Monoclonal

For Research Use Only. Not for use in diagnostic procedures. Catalog #: MBS5818753

Solanezumab is a humanized monoclonal IgG1 antibody directed against the mid-domain of the amyloid-beta (Abeta) peptide. Solanezumab has the potential for the research of Alzheimer's disease. More details

Product Documentation
PDF
Sample Manual Insert View PDF
PDF
Testing Data View PDF
PDF
Certificate of Analysis (COA) View PDF
PDF
QC Report View PDF
PDF
Material Safety Data Sheet View PDF
PDF
Technical Datasheet View PDF
PDF
Protocol View PDF

Product Overview

Online Datasheet in PDF
Product Name
Solanezumab, Monoclonal Antibody
Full Product Name
Solanezumab
Clonality
Monoclonal
Host
Human
Species Reactivity
Amyloid-beta (Abeta)
Preparation and Storage
Powder: -20 degree C for 3 years | In solvent: -80 degree C for 1 year
Molecular Weight
144.1 (kDa)
Solubility
(< 1 mg/ml refers to the product slightly soluble or insoluble)
CAS Number
955085-14-0

Other Notes

Small volumes of anti-Solanezumab antibody vial(s) may occasionally become entrapped in the seal of the product vial during shipment and storage. If necessary, briefly centrifuge the vial on a tabletop centrifuge to dislodge any liquid in the container`s cap. Certain products may require to ship with dry ice and additional dry ice fee may apply.

Searchable Terms for Solanezumab purchase

MBS5818753 is an antibody targeting Solanezumab. Reactive in Amyloid-beta (Abeta). Host: Human.
Request a Quote

Please fill out the form below and our representative will get back to you shortly.

MBS000000
Contact Us

Please fill out the form below and our representative will get back to you shortly.

MBS000000